HK1015410A1 - Replacement therapy for dental caries. - Google Patents

Replacement therapy for dental caries.

Info

Publication number
HK1015410A1
HK1015410A1 HK99100440A HK99100440A HK1015410A1 HK 1015410 A1 HK1015410 A1 HK 1015410A1 HK 99100440 A HK99100440 A HK 99100440A HK 99100440 A HK99100440 A HK 99100440A HK 1015410 A1 HK1015410 A1 HK 1015410A1
Authority
HK
Hong Kong
Prior art keywords
dental caries
replacement therapy
recombinant
mutans strains
production
Prior art date
Application number
HK99100440A
Other languages
English (en)
Inventor
Jeffrey D Hillman
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of HK1015410A1 publication Critical patent/HK1015410A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
HK99100440A 1995-06-07 1999-02-02 Replacement therapy for dental caries. HK1015410A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/486,037 US5607672A (en) 1995-06-07 1995-06-07 Replacement therapy for dental caries
PCT/US1996/009667 WO1996040865A1 (en) 1995-06-07 1996-06-07 Replacement therapy for dental caries

Publications (1)

Publication Number Publication Date
HK1015410A1 true HK1015410A1 (en) 1999-10-15

Family

ID=23930361

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99100440A HK1015410A1 (en) 1995-06-07 1999-02-02 Replacement therapy for dental caries.

Country Status (16)

Country Link
US (1) US5607672A (pt)
EP (1) EP0832186B1 (pt)
JP (1) JP4027970B2 (pt)
CN (1) CN1149280C (pt)
AT (1) ATE248216T1 (pt)
AU (1) AU702384B2 (pt)
BR (1) BR9609041A (pt)
CA (1) CA2223906C (pt)
DE (1) DE69629689T2 (pt)
DK (1) DK0832186T3 (pt)
ES (1) ES2205038T3 (pt)
HK (1) HK1015410A1 (pt)
NZ (1) NZ310289A (pt)
PT (1) PT832186E (pt)
RU (1) RU2224794C2 (pt)
WO (1) WO1996040865A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932469A (en) 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
US6475771B1 (en) 1997-06-10 2002-11-05 University Of Florida Research Foundation Antimicrobial polypeptides and methods of use
US6964760B2 (en) 1997-06-10 2005-11-15 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US6218362B1 (en) 1997-09-08 2001-04-17 Universite Laval Lantibiotic from Streptococcus mutans and uses thereof
DE10108900B4 (de) 2001-02-23 2005-03-10 3M Espe Ag Ermittlung des patientenbezogenen Kariesrisikos
EP1287745A1 (en) 2001-08-24 2003-03-05 The Procter & Gamble Company Chewable compositions with probiotic agents
US20040101494A1 (en) 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
CN102389390A (zh) * 2003-08-11 2012-03-28 奥洁克公司 维持口腔健康的组合物及方法
US20060003454A1 (en) * 2004-07-02 2006-01-05 Conjugon, Inc. Non-dividing donor cells for gene transfer
US9968526B1 (en) 2005-01-24 2018-05-15 Dental Alliance Holdings, Lll System for caries management by risk assessment
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
WO2007077210A1 (en) * 2006-01-04 2007-07-12 Wikstroem Maude Probiotic oral health promoting product
US9427384B2 (en) 2006-01-23 2016-08-30 Dental Alliance Holdings, Llc System for caries management by risk assessment
US10143633B2 (en) 2006-10-16 2018-12-04 Dental Alliance Holdings, Llc Treating cariogenic diseased oral biofilm with elevated pH
ES2606349T3 (es) 2008-06-13 2017-03-23 Oragenics, Inc. Uso de bacterias productoras de peróxido de hidrógeno para el blanqueamiento de los dientes
DK3181682T3 (da) 2008-09-29 2021-07-05 Intrexon Actobiotics Nv Reduceret kolonisering af mikrober på slimhinden
WO2012028759A2 (es) * 2010-08-31 2012-03-08 Centro Superior De Investigación En Salud Pública (Csisp) Composiciones y probióticos/prebióticos anticaries
WO2018013967A1 (en) 2016-07-15 2018-01-18 Intrexon Corporation Lantibiotic variants and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133875A (en) * 1978-02-23 1979-01-09 Forsyth Dental Infirmary For Children Method of controlling dental caries with streptococcus mutans mutant strains
US4324860A (en) * 1978-02-23 1982-04-13 Forsyth Dental Infirmary For Children Lactate dehydrogenase mutants of Streptococcus mutans

Also Published As

Publication number Publication date
DK0832186T3 (da) 2003-12-01
AU6105996A (en) 1996-12-30
NZ310289A (en) 2000-02-28
EP0832186B1 (en) 2003-08-27
DE69629689T2 (de) 2004-06-17
JPH11507228A (ja) 1999-06-29
PT832186E (pt) 2004-01-30
CN1192234A (zh) 1998-09-02
JP4027970B2 (ja) 2007-12-26
EP0832186A4 (en) 2002-03-06
CA2223906C (en) 2010-04-20
RU2224794C2 (ru) 2004-02-27
BR9609041A (pt) 1999-12-14
WO1996040865A1 (en) 1996-12-19
ES2205038T3 (es) 2004-05-01
US5607672A (en) 1997-03-04
AU702384B2 (en) 1999-02-18
DE69629689D1 (de) 2003-10-02
CN1149280C (zh) 2004-05-12
CA2223906A1 (en) 1996-12-19
MX9709598A (es) 1998-06-30
ATE248216T1 (de) 2003-09-15
EP0832186A1 (en) 1998-04-01

Similar Documents

Publication Publication Date Title
HK1015410A1 (en) Replacement therapy for dental caries.
BG100960A (en) Dosage forms for controlled release of azitromycin
EG21210A (en) Process for preparing of antiseptic dentifrice
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
ZA937148B (en) Dioic acids.
AU8658298A (en) Method for preventing and treating hearing loss using a neurturin protein product
NZ502610A (en) Use of lactobacillus for reduction of the fibrinogen level in blood
GB8806737D0 (en) Therapeutic composition & method
UA48965C2 (uk) Композиція та спосіб для лікування гіперсенситивності зубів, спосіб герметизації дентинових канальців
PL320484A1 (en) Method of treating diabetes using kgf
HUP0100016A2 (hu) Készítmények baktériumszaporodás ellenőrzésére
CA2158036A1 (en) 3,4-Diarylchromans for Treatment of Dermatitis
AU6857887A (en) Therapeutic agent
AU6700290A (en) Method for the fermentative production of diacetyl and acetoin using lactic acid bacterium
HUP9600325A1 (en) Dna sequence coding for delta-7-red protein of a. thaliana having a delta-5,7 sterol, delta-7 reductase activity, delta-7-red protein, production process, strains of transformed yeasts and their uses
AU5323396A (en) Methods of treating inflammation and compositions therefor
AU6051898A (en) Facilitation of wound healing with cm101/gbs toxin
AU1781495A (en) Vaccine for nontypable haemophilus influenzae strain
ZA969111B (en) Lactic ferments and their use for the production of hypocholesterolaemic products.
EP1105156A4 (en) NON-VIRULENT PORPHYROMONAS GINGIVALIS MUTANTE
EP0904094A4 (en) TREATMENT OF BONE DISEASES USING ADRENOMEDULLINE
AU2002361172A1 (en) Yeast-based curative and care product and method for making same
GEP19970774B (en) Trichosporon kashiwayama strain-producer of substance possessing stimulating action on repair processes of skin and method of producing substance possessing stimulating action on repair processes of skin
MY104077A (en) Oral compositions
MX9703097A (es) Procedimiento para la produccion de formas inhibidas de factores de sangre activados.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130607